Five years' results of the German ARO 04-01 trial of concurrent 72 Gy hyperfractionated accelerated radiation therapy (HART) plus once weekly cisplatinum/5-FU versus mitomycin C/5-FU in stage IV head and neck cancer.
暂无分享,去创建一个
V. Budach | H. Iro | J. Werner | K. Wernecke | S. Tribius | M. Flentje | W. Budach | M. Bleif | M. Wittlinger | S. Staar | R. Engenhart-Cabillic | G. Becker | C. Cho | B. Sedlmaier | M. Hautmann | P. Feyer | L. Moser | J. Strutz | Beatrix Hueltenschmidt